Income Performance:
The company reported an operating income of -$17.42 million for Q3 2025, representing a staggering YoY decline of 1,262.75% compared to the same quarter last year, revealing substantial operational inefficiencies and higher expenditures. Net income was similarly distressed at -$17.42 million, reflecting a monumental YoY decline of 919.67% and a QoQ decline of 1,535.31%.
Cash Flow Analysis:
Positive operating cash flow of $2.63 million was documented, driven by strategic reductions in expenses and effective management of working capital, indicating operational improvements albeit insufficient to offset heavy losses.
Balance Sheet Health:
The balance sheet reflects total liabilities of $3.87 million against total assets of $4.55 million. The company’s total shareholder equity remains precariously low at $680,000, with a severely negative retained earnings balance of $88.25 million, indicating accumulated operational losses and the substantial need for future profitability. The current ratio of 0.0354 suggests illiquidity risks that may hinder operational capabilities.